Predictive Oncology Inc. (POAI)
NASDAQ: POAI · IEX Real-Time Price · USD
1.090
-0.080 (-6.84%)
At close: Jul 19, 2024, 4:00 PM
1.050
-0.040 (-3.67%)
Pre-market: Jul 22, 2024, 8:55 AM EDT
Predictive Oncology Employees
As of December 31, 2023, Predictive Oncology had 35 total employees, including 34 full-time and 1 part-time employees. The number of employees increased by 1 or 2.94% compared to the previous year.
Employees
35
Change (1Y)
1
Growth (1Y)
2.94%
Revenue / Employee
$55,996
Profits / Employee
-$422,315
Market Cap
4.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Genetic Technologies | 60 |
Trevena | 23 |
Theriva Biologics | 22 |
Sonnet BioTherapeutics Holdings | 12 |
Adial Pharmaceuticals | 7 |
Portage Biotech | 7 |
Allarity Therapeutics | 6 |
Evoke Pharma | 4 |
POAI News
- 5 weeks ago - Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs) - GlobeNewsWire
- 6 weeks ago - Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery - GlobeNewsWire
- 7 weeks ago - Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024 - GlobeNewsWire
- 7 weeks ago - Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 months ago - Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024 - GlobeNewsWire
- 3 months ago - Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 4 months ago - Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update - GlobeNewsWire